PrEP inequities have worsened in the US over the last decade, both racially and regionally
Six-country study shows dolutegravir-based treatment is highly effective in children and adolescents
Gaps in U=U awareness globally: healthcare providers need to do more to get the message out
Weight gain on treatment: more evidence that TAF plus dolutegravir leads to greater gains
Widespread PrEP use is not leading to more hepatitis C transmission among gay and bisexual men
ViiV Healthcare to allow 90 countries to access generic versions of HIV prevention shot
Taking antibiotic after sex cuts STIs by two-thirds, ‘DoxyPEP’ study finds
Why do people with HIV delay hepatitis C treatment?
Simple changes in clinic processes can yield big improvements in viral load testing, Malawi study shows
